Overview:
For more than 50 years, bioMérieux's activities have been concentrated in the health sector and in particular in the development, production and marketing in more than 150 countries of instruments and reagents for clinical and microbiological testing in the pharmaceutical, cosmetic, food and environmental industries. In the Florence plant, bioMeriéux produces 3700 in vitro diagnostic instruments per year, among the most advanced on the market, with the most modern manufacturing technologies, through controlled and validated processes guaranteeing high quality standards. The Florence site is ISO 9001 and ISO 13485 certified and meets FDA requirements.
